Merck & Co., Inc. Elects Risa Lavizzo-Mourey to the Board of Directors

The leading American multinational pharmaceutical company Merck & Co., Inc. elected Risa Lavizzo-Mourey,M.D. to the board of directors of the company. The appointment was announced at the annual general meeting of the shareholders. Risa is a world-renowned expert in health policy and geriatric medicine.

Merck & Co. Inc. is an innovative, global healthcare leader that is committed to improving health and wellbeing around the world. Their core product categories include diabetes, cancer, vaccines and hospital acute care. They are a $44.3 billion company With 69000 employees and are based in New Jersey.